Corbevax approved as booster dose for adults with Covaxin, Covisheeld vaccines: report



Corbevax approved as booster dose for adults with Covaxin, Covisheeld vaccines: report

Biologic E’s Corbevax is approved as a booster dose for vaccinated adults who have received Covishield or Covaxin

New Delhi:

The government has approved Biologics E’s Corbevax as a precautionary dose or booster jab for people above 18 years of age, official sources said today.

This is the first time that a booster dose has been allowed in the country which is different from the dose used for primary vaccination against COVID.

Sources told the Press Trust of India that the Union Health Ministry’s approval is based on the recommendations made by the COVID-19 Working Group of the National Technical Advisory Group on Immunization (NTAGI) recently.

“Corbevax shall be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of Covaxin or CovaShield vaccines to persons over 18 years of age who have been diagnosed with Corbavax as an asymptomatic COVID- 19 enables use as a vaccine. Precautionary dose administration in this age group,” sources told the Press Trust of India.

Sources said that this would be in addition to the existing guidelines for home precautionary dosage administration of Covaxin and Covishield Vaccine.

All necessary changes are being made regarding the administration of the precautionary dose of Corbevax vaccine on the Co-WIN portal.

India’s first indigenously developed RBD protein subunit vaccine Corbevax is currently being used to vaccinate children aged 12 to 14 years under the COVID-19 vaccination programme.

The COVID-19 Working Group (CWG), at its July 20 meeting, reviewed data from a double-blind randomized phase-3 clinical study that found the immunogenicity and immunity of a booster dose of Corbevax vaccine when administered to a COVID-19-negative adult. Security rated. Volunteers aged 18–80 years were previously vaccinated with either Covishield or two doses of Covaxin.

“After examining the data, the CWG observed that Corbevax vaccine could induce a significant increase in antibody titers when Covaxin or Covishield has been received, which according to the neutralization data is likely to be protective,” the sources told the news. . Agency PTI.

The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precautionary dose for people aged 18 years and above.

India began giving precautionary doses of vaccines to health care and frontline workers and people aged 60 and above from January 10.

The country began immunizing children aged 12-14 years from March 16 and also removed the comorbidity clause, making everyone over the age of 60 eligible for a precautionary dose of the COVID vaccine.

India began giving a precautionary dose or booster dose of COVID-19 vaccines to all people over the age of 18 on 10 April.

(Except for the title, this story has not been edited by NDTV staff and is published from a syndicated feed.)


Source link


Please enter your comment!
Please enter your name here